[1P] 62 Schizophrenia

[1P-461] Phosphoproteomic Insights into Methamphetamine-Induced Cognitive Dysfunction in Mice Carrying Schizophrenia-Associated Variations

*WENJUN ZHU¹, Rinako Tanaka¹, Tetsuo Matsuzaki¹, Hiroyuki Mizoguchi¹, Kaibuchi Kozo⁵, Ozaki Norio², Toshitaka Nabeshima⁴, Taku Nagai³, Kiyofumi Yamada¹ (1. Neuropsychopharmacology and Hospital Pharmacy, Graduate school of medicine, Nagoya University, Nagoya,Aichi, Japan, 2. Department of Psychiatry, Nagoya University Graduate School of Medicine, Nag oya, Aichi, Japan, 3. Division of Behavioral Neuropharmacology, International center for brain sci ence, Fujita Health University, Aichi, Japan, 4. Advanced Diagnostic System Research Laboratory Fujita Health University, Gra duate School of Health Sciences & Aino University, Toyoake, Aichi, Japan., 5. Division of Cell Biology, International Center for Brain Science(ICBS), Fuji ta Health University, Aichi, Japan)

Keywords:Phosphoproteomics, Schizophrenia, Cognitive dysfunction, Rho kinase